News Image

EXELIXIS INC (NASDAQ:EXEL) – A Strong Contender in High Growth Momentum and Minervini’s Trend Template

By Mill Chart

Last update: May 17, 2025

EXELIXIS INC (NASDAQ:EXEL) has been identified as a high-growth momentum stock that also aligns with Mark Minervini’s Trend Template criteria. The company, focused on developing oncology treatments, demonstrates both technical strength and robust fundamental growth, making it a compelling candidate for investors seeking high-growth opportunities.

EXELIXIS stock chart

Why EXEL Fits Minervini’s Trend Template

Minervini’s strategy emphasizes stocks in strong uptrends with clear technical strength. EXEL meets these criteria:

  • Price Above Key Moving Averages:

    • Current price ($45.40) is above the 50-day ($37.41), 150-day ($35.13), and 200-day ($32.85) moving averages.
    • The 50-day MA is above both the 150-day and 200-day MAs, confirming bullish alignment.
  • Upward-Trending Moving Averages:

    • The 200-day MA is rising, reinforcing long-term strength.
  • Strong Relative Strength:

    • EXEL outperforms 97% of all stocks, with a relative strength score of 97.66.
  • Price Near 52-Week High:

    • Trading at $45.40, EXEL is within 7% of its 52-week high ($48.85) and 125% above its 52-week low ($20.14).

High Growth Momentum Fundamentals

Beyond technicals, EXEL exhibits strong growth metrics:

  • Earnings Growth:

    • EPS (TTM) grew 205.6% year-over-year.
    • Quarterly EPS growth surged 175% in the most recent quarter.
  • Revenue Expansion:

    • Revenue (TTM) increased 18.5% year-over-year.
    • Quarterly sales rose 30.6% compared to the same quarter last year.
  • Profitability Improvements:

    • Profit margins expanded to 24.7% in the latest quarter, up from 21.9% in the prior quarter.
    • Free cash flow per share grew 129.3% year-over-year.
  • Analyst Confidence:

    • EPS and revenue estimates for next year have been revised upward by 5.1% over the past three months.

Technical Outlook

EXEL’s technical rating of 10/10 reflects its strong uptrend, high relative strength, and consistent performance. However, the setup rating of 2/10 suggests the stock may be extended in the short term, indicating a potential consolidation before another breakout.

For a deeper technical analysis, review the full EXEL technical report.

Our High Growth Momentum + Trend Template screener lists more stocks meeting these criteria.

Disclaimer

This is not investment advice. Always conduct your own research before making investment decisions.

EXELIXIS INC

NASDAQ:EXEL (5/16/2025, 8:00:02 PM)

After market: 45.04 -0.36 (-0.79%)

45.4

-0.86 (-1.86%)



Find more stocks in the Stock Screener

EXEL Latest News and Analysis

ChartMill News Imagea few seconds ago - ChartmillEXELIXIS INC (NASDAQ:EXEL) – A Strong Contender in High Growth Momentum and Minervini’s Trend Template

EXELIXIS INC (NASDAQ:EXEL) meets Minervini’s Trend Template with strong technicals and high growth momentum, making it a standout in biotech. Review its full technical and fundamental strengths before considering an investment.

ChartMill News Image19 days ago - ChartmillFor those who appreciate growth without the sticker shock, EXELIXIS INC (NASDAQ:EXEL) is worth considering.

Discover EXELIXIS INC, an undervalued growth gem. NASDAQ:EXEL is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing valuation.

Follow ChartMill for more